Welcome, how can we help?
Policy Types
Getting Technical

 

Home / Types of Life Insurance Policies / - Bright Grey, Life Insurance Company

Bright Grey logo

Bright Grey is a division of The Royal London Mutual Insurance Society Limited and acts as the groups’ protection (life insurance, income protection, and critical illness) specialist.

As a specialist division within the Royal London Group, Bright Grey focuses purely on protection insurance. Bright Grey channelled their efforts into developing a range of covers that can be mixed and matched to create a protection plan that meets the customers needs exactly.

Royal London was established over 150 years ago as a mutual insurer. This means that they have no “shareholders”, the business is owned by the “members”. The members share in the profits of the business in the form of bonuses paid on with profit policies.

The Royal London Group also includes Scottish Life, Bright Grey and Royal London Asset Management. Royal London took over Refuge Assurance and United Friendly in 2000 and Scottish Life in 2001.

Royal London Group are the UK's largest mutual life and pensions company. The Group has over three million customers and funds under management of £29.5 billion (as at September 2006).

Back  button

NEWS
Share of drug company rises after Alzheimers trial has positive outcome

17 June 2008 17:20:44
Shares of a drug making company have risen dramatically after they announced the successful trial of an experimental Alzheimer's treatment, Bloomberg has reported.

Elan Corp's shares rose to the highest level in three years and Wyeth jumped 4.8 per cent in New York trading after declaring results of tests for their bapineuzumab drug.

The tests should that bapineuzumab could increase the cognitive ability of patients who carry a gene tied to as many as 70 percent of Alzheimers cases.

Talking about the trials which did not benefit those with the ApoE4 gene, Ian Hunter, Goodbody stockbrokers analyst, said: "This set of data is much better than we expected, given the strong response observed in non-ApoE4 carriers.'

Bapineuzumab, a man-made antibody, works by removing protein deposits from the brain of affected patients.

Further tests are required to get the drug to the final stage of regulatory approval as it failed to meet the main goal of the initial trial.

Alzheimer's is the most common cause of dementia and is a degenerative and terminal disease for which there is currently no known cure.ADNFCR-980-ID-18643113-ADNFCR


Waking up to stroke awareness

15 November 2007 11:31:24
Anyone in doubt about the importance of critical illness cover has been reminded that a stroke can happen "to anyone at any age".

According to the Stroke Association, there is a common misconception that the third most common cause of death in England and Wales only affects older - particularly male - members of the population.

Catching up with heart disease and cancer, strokes are estimated to cause over 67,000 deaths in the UK every year, with around 150,000 people experiencing one in that period.

A spokesperson for the Stroke Association pointed out that although most people affected are over 65, anyone can have a stroke, including children and even babies.

"There always needs to be more awareness of the risk factors with stroke," emphasised the charity's representative.

"High blood pressure is the single biggest factor of stroke and obviously people don't realise they have high blood pressure unless they get it measured, so it's vitally important that people do it regularly," she added.

The Stroke Association recommends that people exercise regularly, stop smoking and eat healthily to bring down high blood pressure.

Around 300,000 people are living with moderate to severe disabilities as a result of stroke.

Direct Life and Pensions Services Ltd are one of the UK's leading providers of life insurance, term life assurance, mortgage protection, critical illness and life insurance advice onlineADNFCR-980-ID-18356585-ADNFCR


MS patient wins judicial review

11 June 2008 17:05:21
A woman suffering from multiple sclerosis has been granted a full hearing to clarify the UK's stance on the law regarding assisted suicide.

Ms Debbie Purdy fears that if she decides to end her life in a country such as Switzerland where clinics are available to help her, her husband may be prosecuted when he returns to the UK, if he accompanies her.

Ms Purdy, who was diagnosed with primary progressive MS in March 1995 and is wheelchair bound, explained: "I am delighted that the courts have decided to officially review the law surrounding my case.

"If the Director of Public Prosecutions (DPP) does clarify that my husband will not be prosecuted for accompanying me I will be able to wait until I'm ready to go."

At present Mr Purdy could face up to 14 years in prison for aiding or abetting a suicide.

Multiple sclerosis is a degenerative disease of the central nervous system and according to the World Health Organisation, it affects about 2.5 million people worldwide, of which about one per cent die each year. ADNFCR-980-ID-18634471-ADNFCR